KORU Medical Systems, Inc. (KRMD)
USD 3.7
(-10.19%)
USD 3.7
(-10.19%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 16.7 Million USD | 3.05% |
| 2022 | 15.36 Million USD | 11.62% |
| 2021 | 13.76 Million USD | -7.81% |
| 2020 | 14.93 Million USD | 0.55% |
| 2019 | 14.85 Million USD | 37.4% |
| 2018 | 10.81 Million USD | 14.3% |
| 2017 | 9.45 Million USD | 24.95% |
| 2016 | 7.56 Million USD | -0.44% |
| 2015 | 7.6 Million USD | 13.68% |
| 2014 | 6.68 Million USD | 25.94% |
| 2013 | 5.31 Million USD | 7.39% |
| 2012 | 4.94 Million USD | 19.47% |
| 2011 | 4.13 Million USD | 26.83% |
| 2010 | 3.26 Million USD | 29.95% |
| 2009 | 2.51 Million USD | 14.38% |
| 2008 | 2.19 Million USD | 51.67% |
| 2007 | 1.44 Million USD | 35.16% |
| 2006 | 1.07 Million USD | 5.29% |
| 2005 | 1.01 Million USD | 22.01% |
| 2004 | 833.76 Thousand USD | 3.59% |
| 2003 | 804.83 Thousand USD | 15.47% |
| 2002 | 697.01 Thousand USD | 62.88% |
| 2001 | 427.94 Thousand USD | -56.28% |
| 2000 | 978.94 Thousand USD | 4.16% |
| 1999 | 939.84 Thousand USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 5.26 Million USD | 12.48% |
| 2024 Q1 | 4.87 Million USD | 18.75% |
| 2023 FY | 15.83 Million USD | 3.05% |
| 2023 Q3 | 4.34 Million USD | 11.68% |
| 2023 Q2 | 3.88 Million USD | -6.24% |
| 2023 Q4 | 4.1 Million USD | -5.52% |
| 2023 Q1 | 4.14 Million USD | 1.69% |
| 2022 Q4 | 4.07 Million USD | -5.65% |
| 2022 Q2 | 3.34 Million USD | -7.62% |
| 2022 Q3 | 4.32 Million USD | 29.17% |
| 2022 Q1 | 3.62 Million USD | -5.47% |
| 2022 FY | 15.36 Million USD | 11.62% |
| 2021 FY | 13.76 Million USD | -7.81% |
| 2021 Q1 | 3.23 Million USD | 40.68% |
| 2021 Q2 | 3.21 Million USD | -0.67% |
| 2021 Q4 | 3.83 Million USD | 9.61% |
| 2021 Q3 | 3.49 Million USD | 8.9% |
| 2020 FY | 14.93 Million USD | 0.55% |
| 2020 Q3 | 3.94 Million USD | -19.74% |
| 2020 Q4 | 2.29 Million USD | -41.7% |
| 2020 Q1 | 3.78 Million USD | -4.03% |
| 2020 Q2 | 4.9 Million USD | 29.61% |
| 2019 Q4 | 3.94 Million USD | -9.94% |
| 2019 FY | 14.85 Million USD | 37.4% |
| 2019 Q3 | 4.38 Million USD | 26.1% |
| 2019 Q2 | 3.47 Million USD | 14.03% |
| 2019 Q1 | 3.04 Million USD | 12.33% |
| 2018 Q3 | 2.89 Million USD | 5.55% |
| 2018 FY | 10.81 Million USD | 14.3% |
| 2018 Q4 | 2.71 Million USD | -6.16% |
| 2018 Q1 | 2.46 Million USD | -17.5% |
| 2018 Q2 | 2.73 Million USD | 11.1% |
| 2017 Q4 | 2.98 Million USD | 25.65% |
| 2017 Q2 | 2.29 Million USD | 42.32% |
| 2017 Q1 | 1.61 Million USD | -21.79% |
| 2017 FY | 9.45 Million USD | 24.95% |
| 2017 Q3 | 2.37 Million USD | 3.54% |
| 2016 FY | 7.56 Million USD | -0.44% |
| 2016 Q1 | 1.96 Million USD | -6.65% |
| 2016 Q4 | 2.06 Million USD | 5.59% |
| 2016 Q3 | 1.95 Million USD | 0.92% |
| 2016 Q2 | 1.93 Million USD | -1.64% |
| 2015 Q4 | 2.1 Million USD | 5.11% |
| 2015 Q3 | 2 Million USD | 32.21% |
| 2015 Q2 | 1.51 Million USD | -21.96% |
| 2015 Q1 | 1.94 Million USD | 23.1% |
| 2015 FY | 7.6 Million USD | 13.68% |
| 2014 Q3 | 1.63 Million USD | 7.23% |
| 2014 Q4 | 1.57 Million USD | -3.45% |
| 2014 FY | 6.68 Million USD | 25.94% |
| 2014 Q1 | 1.61 Million USD | 21.94% |
| 2014 Q2 | 1.52 Million USD | -5.55% |
| 2013 Q4 | 1.32 Million USD | 10.43% |
| 2013 Q2 | 1.16 Million USD | -7.6% |
| 2013 FY | 5.31 Million USD | 7.39% |
| 2013 Q1 | 1.26 Million USD | -1.74% |
| 2013 Q3 | 1.2 Million USD | 2.66% |
| 2012 Q2 | 1.1 Million USD | -21.19% |
| 2012 Q4 | 1.28 Million USD | 0.17% |
| 2012 Q3 | 1.28 Million USD | 16.13% |
| 2012 FY | 4.94 Million USD | 19.47% |
| 2012 Q1 | 1.4 Million USD | 54.0% |
| 2011 FY | 4.13 Million USD | 26.83% |
| 2011 Q1 | 1.08 Million USD | 29.02% |
| 2011 Q2 | 953.78 Thousand USD | -12.32% |
| 2011 Q3 | 869.15 Thousand USD | -8.87% |
| 2011 Q4 | 911.89 Thousand USD | 4.92% |
| 2010 Q2 | 619.55 Thousand USD | -20.69% |
| 2010 FY | 3.26 Million USD | 29.95% |
| 2010 Q4 | 843.11 Thousand USD | 18.24% |
| 2010 Q1 | 781.19 Thousand USD | 32.79% |
| 2010 Q3 | 713.06 Thousand USD | 15.09% |
| 2009 Q4 | 588.3 Thousand USD | -8.27% |
| 2009 FY | 2.51 Million USD | 14.38% |
| 2009 Q1 | 627.51 Thousand USD | 16.06% |
| 2009 Q3 | 641.37 Thousand USD | 28.12% |
| 2009 Q2 | 500.59 Thousand USD | -20.23% |
| 2008 Q2 | 451.26 Thousand USD | 2.74% |
| 2008 Q1 | 439.22 Thousand USD | 11.3% |
| 2008 FY | 2.19 Million USD | 51.67% |
| 2008 Q4 | 540.67 Thousand USD | -12.61% |
| 2008 Q3 | 618.68 Thousand USD | 37.1% |
| 2007 FY | 1.44 Million USD | 35.16% |
| 2007 Q3 | 416.11 Thousand USD | 110.36% |
| 2007 Q4 | 394.63 Thousand USD | -5.16% |
| 2007 Q2 | 197.81 Thousand USD | -42.67% |
| 2007 Q1 | 345.05 Thousand USD | 34.11% |
| 2006 Q1 | 229.36 Thousand USD | -33.52% |
| 2006 Q3 | 271.31 Thousand USD | 37.44% |
| 2006 Q4 | 257.28 Thousand USD | -5.17% |
| 2006 FY | 1.07 Million USD | 5.29% |
| 2006 Q2 | 197.41 Thousand USD | -13.93% |
| 2005 Q2 | 203.64 Thousand USD | 15.22% |
| 2005 FY | 1.01 Million USD | 22.01% |
| 2005 Q4 | 345.02 Thousand USD | 39.47% |
| 2005 Q3 | 247.38 Thousand USD | 21.48% |
| 2005 Q1 | 176.73 Thousand USD | 0.0% |
| 2004 FY | 833.76 Thousand USD | 3.59% |
| 2004 Q2 | 287.67 Thousand USD | 64.94% |
| 2004 Q3 | 192.61 Thousand USD | -33.04% |
| 2004 Q4 | 176.73 Thousand USD | -8.25% |
| 2004 Q1 | 174.41 Thousand USD | -13.35% |
| 2003 Q1 | 312.14 Thousand USD | 157.12% |
| 2003 FY | 804.83 Thousand USD | 15.47% |
| 2003 Q4 | 201.29 Thousand USD | 1.53% |
| 2003 Q3 | 198.26 Thousand USD | -14.12% |
| 2003 Q2 | 230.85 Thousand USD | -26.04% |
| 2002 FY | 697.01 Thousand USD | 62.88% |
| 2002 Q4 | 121.39 Thousand USD | -17.91% |
| 2002 Q3 | 147.88 Thousand USD | 25.35% |
| 2002 Q2 | 117.97 Thousand USD | 47.98% |
| 2002 Q1 | 79.72 Thousand USD | -22.46% |
| 2001 Q1 | 273.73 Thousand USD | 32.41% |
| 2001 FY | 427.94 Thousand USD | -56.28% |
| 2001 Q4 | 102.82 Thousand USD | -25.02% |
| 2001 Q3 | 137.14 Thousand USD | 26.68% |
| 2001 Q2 | 108.25 Thousand USD | -60.45% |
| 2000 FY | 978.94 Thousand USD | 4.16% |
| 2000 Q2 | 222.41 Thousand USD | 0.0% |
| 2000 Q4 | 206.73 Thousand USD | -11.77% |
| 2000 Q3 | 234.3 Thousand USD | 5.35% |
| 1999 FY | 939.84 Thousand USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 56.3 Million USD | 70.325% |
| AngioDynamics, Inc. | 154.69 Million USD | 89.199% |
| AtriCure, Inc. | 300.37 Million USD | 94.437% |
| Avinger, Inc. | 2 Million USD | -734.163% |
| Azenta, Inc. | 263.14 Million USD | 93.65% |
| BioLife Solutions, Inc. | 46.75 Million USD | 64.262% |
| The Cooper Companies, Inc. | 2.35 Billion USD | 99.291% |
| Daxor Corporation | 1.1 Million USD | -1414.199% |
| Ekso Bionics Holdings, Inc. | 9.07 Million USD | -84.032% |
| Femasys Inc. | 691.9 Thousand USD | -2314.837% |
| GlucoTrack, Inc. | -13 Thousand USD | 128625.246% |
| Harvard Bioscience, Inc. | 60.86 Million USD | 72.549% |
| Hologic, Inc. | 2.22 Billion USD | 99.25% |
| ICU Medical, Inc. | 739.87 Million USD | 97.742% |
| Intuitive Surgical, Inc. | 4.72 Billion USD | 99.647% |
| LeMaitre Vascular, Inc. | 127.04 Million USD | 86.849% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 14101.862% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 14101.862% |
| Masimo Corporation | 1 Billion USD | 98.335% |
| Microbot Medical Inc. | -106 Thousand USD | 15862.53% |
| Meihua International Medical Technologies Co., Ltd. | 33.09 Million USD | 49.514% |
| Merit Medical Systems, Inc. | 583.87 Million USD | 97.138% |
| Nephros, Inc. | 8.4 Million USD | -98.79% |
| NovoCure Limited | 381.05 Million USD | 95.615% |
| NEXGEL, Inc. | 619 Thousand USD | -2599.238% |
| NEXGEL, Inc. | 619 Thousand USD | -2599.238% |
| Singular Genomics Systems, Inc. | -558 Thousand USD | 3094.316% |
| OraSure Technologies, Inc. | 179.42 Million USD | 90.688% |
| Pro-Dex, Inc. | 14.55 Million USD | -14.826% |
| Pulse Biosciences, Inc. | -1.2 Million USD | 1484.282% |
| Predictive Oncology Inc. | 1.14 Million USD | -1358.86% |
| Precision Optics Corporation, Inc. | 5.79 Million USD | -188.184% |
| QuidelOrtho Corporation | 1.49 Billion USD | 98.882% |
| Repligen Corporation | 315.22 Million USD | 94.7% |
| Sanara MedTech Inc. | 57.13 Million USD | 70.758% |
| STAAR Surgical Company | 252.65 Million USD | 93.387% |
| Sharps Technology, Inc. | -891.24 Thousand USD | 1974.706% |
| Utah Medical Products, Inc. | 30.03 Million USD | 44.376% |
| DENTSPLY SIRONA Inc. | 2.08 Billion USD | 99.199% |
| Jin Medical International Ltd. | 6.78 Million USD | -146.259% |